Report Detail

Request for Sample of this report

Pharma & Healthcare Global End Stage Renal Disease Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4617185
    • |
  • 26 September, 2024
    • |
  • Global
    • |
  • 129 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.
According to our (Global Info Research) latest study, the global End Stage Renal Disease Treatment market size was valued at US$ 56940 million in 2023 and is forecast to a readjusted size of USD 81580 million by 2030 with a CAGR of 5.3% during review period.
Fresenius is one of the most important global key players of the end stage renal disease treatment, holds about 20% of shares of the global end stage renal disease treatment market, other key players include DaVita, Baxter, etc. North America is the largest market, occupied for about 40 percent, followed by the Asia Pacific. In terms of type, hemodialysis is the largest segment, with a share of about 70%, and in terms of application, the kidney dialysis centers segment holds a share of over 60 percent.
This report is a detailed and comprehensive analysis for global End Stage Renal Disease Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global End Stage Renal Disease Treatment market size and forecasts, in consumption value ($ Million), 2019-2030
Global End Stage Renal Disease Treatment market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global End Stage Renal Disease Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global End Stage Renal Disease Treatment market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for End Stage Renal Disease Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global End Stage Renal Disease Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO, Newsol, Mayo Clinic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
End Stage Renal Disease Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
End Stage Renal Disease Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hemodialysis
Peritoneal Dialysis
Kidney Transplantation
Market segment by Application
Hospitals
Kidney Dialysis Centers
At Homes
Others
Market segment by players, this report covers
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Nikkiso
WEGO
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe End Stage Renal Disease Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of End Stage Renal Disease Treatment, with revenue, gross margin, and global market share of End Stage Renal Disease Treatment from 2019 to 2024.
Chapter 3, the End Stage Renal Disease Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and End Stage Renal Disease Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of End Stage Renal Disease Treatment.
Chapter 13, to describe End Stage Renal Disease Treatment research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of End Stage Renal Disease Treatment by Type
    • 1.3.1 Overview: Global End Stage Renal Disease Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global End Stage Renal Disease Treatment Consumption Value Market Share by Type in 2023
    • 1.3.3 Hemodialysis
    • 1.3.4 Peritoneal Dialysis
    • 1.3.5 Kidney Transplantation
  • 1.4 Global End Stage Renal Disease Treatment Market by Application
    • 1.4.1 Overview: Global End Stage Renal Disease Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Kidney Dialysis Centers
    • 1.4.4 At Homes
    • 1.4.5 Others
  • 1.5 Global End Stage Renal Disease Treatment Market Size & Forecast
  • 1.6 Global End Stage Renal Disease Treatment Market Size and Forecast by Region
    • 1.6.1 Global End Stage Renal Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global End Stage Renal Disease Treatment Market Size by Region, (2019-2030)
    • 1.6.3 North America End Stage Renal Disease Treatment Market Size and Prospect (2019-2030)
    • 1.6.4 Europe End Stage Renal Disease Treatment Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific End Stage Renal Disease Treatment Market Size and Prospect (2019-2030)
    • 1.6.6 South America End Stage Renal Disease Treatment Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa End Stage Renal Disease Treatment Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Fresenius
    • 2.1.1 Fresenius Details
    • 2.1.2 Fresenius Major Business
    • 2.1.3 Fresenius End Stage Renal Disease Treatment Product and Solutions
    • 2.1.4 Fresenius End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Fresenius Recent Developments and Future Plans
  • 2.2 DaVita
    • 2.2.1 DaVita Details
    • 2.2.2 DaVita Major Business
    • 2.2.3 DaVita End Stage Renal Disease Treatment Product and Solutions
    • 2.2.4 DaVita End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 DaVita Recent Developments and Future Plans
  • 2.3 Baxter
    • 2.3.1 Baxter Details
    • 2.3.2 Baxter Major Business
    • 2.3.3 Baxter End Stage Renal Disease Treatment Product and Solutions
    • 2.3.4 Baxter End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Baxter Recent Developments and Future Plans
  • 2.4 Nipro
    • 2.4.1 Nipro Details
    • 2.4.2 Nipro Major Business
    • 2.4.3 Nipro End Stage Renal Disease Treatment Product and Solutions
    • 2.4.4 Nipro End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Nipro Recent Developments and Future Plans
  • 2.5 B. Braun
    • 2.5.1 B. Braun Details
    • 2.5.2 B. Braun Major Business
    • 2.5.3 B. Braun End Stage Renal Disease Treatment Product and Solutions
    • 2.5.4 B. Braun End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 B. Braun Recent Developments and Future Plans
  • 2.6 Asahi Kasei
    • 2.6.1 Asahi Kasei Details
    • 2.6.2 Asahi Kasei Major Business
    • 2.6.3 Asahi Kasei End Stage Renal Disease Treatment Product and Solutions
    • 2.6.4 Asahi Kasei End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Asahi Kasei Recent Developments and Future Plans
  • 2.7 Nikkiso
    • 2.7.1 Nikkiso Details
    • 2.7.2 Nikkiso Major Business
    • 2.7.3 Nikkiso End Stage Renal Disease Treatment Product and Solutions
    • 2.7.4 Nikkiso End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Nikkiso Recent Developments and Future Plans
  • 2.8 WEGO
    • 2.8.1 WEGO Details
    • 2.8.2 WEGO Major Business
    • 2.8.3 WEGO End Stage Renal Disease Treatment Product and Solutions
    • 2.8.4 WEGO End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 WEGO Recent Developments and Future Plans
  • 2.9 Newsol
    • 2.9.1 Newsol Details
    • 2.9.2 Newsol Major Business
    • 2.9.3 Newsol End Stage Renal Disease Treatment Product and Solutions
    • 2.9.4 Newsol End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Newsol Recent Developments and Future Plans
  • 2.10 Mayo Clinic
    • 2.10.1 Mayo Clinic Details
    • 2.10.2 Mayo Clinic Major Business
    • 2.10.3 Mayo Clinic End Stage Renal Disease Treatment Product and Solutions
    • 2.10.4 Mayo Clinic End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Mayo Clinic Recent Developments and Future Plans
  • 2.11 Guangdong Biolight
    • 2.11.1 Guangdong Biolight Details
    • 2.11.2 Guangdong Biolight Major Business
    • 2.11.3 Guangdong Biolight End Stage Renal Disease Treatment Product and Solutions
    • 2.11.4 Guangdong Biolight End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Guangdong Biolight Recent Developments and Future Plans
  • 2.12 Medtronic
    • 2.12.1 Medtronic Details
    • 2.12.2 Medtronic Major Business
    • 2.12.3 Medtronic End Stage Renal Disease Treatment Product and Solutions
    • 2.12.4 Medtronic End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Medtronic Recent Developments and Future Plans
  • 2.13 Sanxin Medtec
    • 2.13.1 Sanxin Medtec Details
    • 2.13.2 Sanxin Medtec Major Business
    • 2.13.3 Sanxin Medtec End Stage Renal Disease Treatment Product and Solutions
    • 2.13.4 Sanxin Medtec End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Sanxin Medtec Recent Developments and Future Plans
  • 2.14 Jafron Biomedical
    • 2.14.1 Jafron Biomedical Details
    • 2.14.2 Jafron Biomedical Major Business
    • 2.14.3 Jafron Biomedical End Stage Renal Disease Treatment Product and Solutions
    • 2.14.4 Jafron Biomedical End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Jafron Biomedical Recent Developments and Future Plans
  • 2.15 SWS Hemodialysis Care
    • 2.15.1 SWS Hemodialysis Care Details
    • 2.15.2 SWS Hemodialysis Care Major Business
    • 2.15.3 SWS Hemodialysis Care End Stage Renal Disease Treatment Product and Solutions
    • 2.15.4 SWS Hemodialysis Care End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 SWS Hemodialysis Care Recent Developments and Future Plans
  • 2.16 Tianyi Medical
    • 2.16.1 Tianyi Medical Details
    • 2.16.2 Tianyi Medical Major Business
    • 2.16.3 Tianyi Medical End Stage Renal Disease Treatment Product and Solutions
    • 2.16.4 Tianyi Medical End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Tianyi Medical Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global End Stage Renal Disease Treatment Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of End Stage Renal Disease Treatment by Company Revenue
    • 3.2.2 Top 3 End Stage Renal Disease Treatment Players Market Share in 2023
    • 3.2.3 Top 6 End Stage Renal Disease Treatment Players Market Share in 2023
  • 3.3 End Stage Renal Disease Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 End Stage Renal Disease Treatment Market: Region Footprint
    • 3.3.2 End Stage Renal Disease Treatment Market: Company Product Type Footprint
    • 3.3.3 End Stage Renal Disease Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global End Stage Renal Disease Treatment Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global End Stage Renal Disease Treatment Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global End Stage Renal Disease Treatment Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global End Stage Renal Disease Treatment Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America End Stage Renal Disease Treatment Consumption Value by Type (2019-2030)
  • 6.2 North America End Stage Renal Disease Treatment Market Size by Application (2019-2030)
  • 6.3 North America End Stage Renal Disease Treatment Market Size by Country
    • 6.3.1 North America End Stage Renal Disease Treatment Consumption Value by Country (2019-2030)
    • 6.3.2 United States End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)
    • 6.3.3 Canada End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe End Stage Renal Disease Treatment Consumption Value by Type (2019-2030)
  • 7.2 Europe End Stage Renal Disease Treatment Consumption Value by Application (2019-2030)
  • 7.3 Europe End Stage Renal Disease Treatment Market Size by Country
    • 7.3.1 Europe End Stage Renal Disease Treatment Consumption Value by Country (2019-2030)
    • 7.3.2 Germany End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)
    • 7.3.3 France End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)
    • 7.3.5 Russia End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)
    • 7.3.6 Italy End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific End Stage Renal Disease Treatment Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific End Stage Renal Disease Treatment Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific End Stage Renal Disease Treatment Market Size by Region
    • 8.3.1 Asia-Pacific End Stage Renal Disease Treatment Consumption Value by Region (2019-2030)
    • 8.3.2 China End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)
    • 8.3.3 Japan End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)
    • 8.3.5 India End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)
    • 8.3.7 Australia End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America End Stage Renal Disease Treatment Consumption Value by Type (2019-2030)
  • 9.2 South America End Stage Renal Disease Treatment Consumption Value by Application (2019-2030)
  • 9.3 South America End Stage Renal Disease Treatment Market Size by Country
    • 9.3.1 South America End Stage Renal Disease Treatment Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa End Stage Renal Disease Treatment Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa End Stage Renal Disease Treatment Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa End Stage Renal Disease Treatment Market Size by Country
    • 10.3.1 Middle East & Africa End Stage Renal Disease Treatment Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)
    • 10.3.4 UAE End Stage Renal Disease Treatment Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 End Stage Renal Disease Treatment Market Drivers
  • 11.2 End Stage Renal Disease Treatment Market Restraints
  • 11.3 End Stage Renal Disease Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 End Stage Renal Disease Treatment Industry Chain
  • 12.2 End Stage Renal Disease Treatment Upstream Analysis
  • 12.3 End Stage Renal Disease Treatment Midstream Analysis
  • 12.4 End Stage Renal Disease Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on End Stage Renal Disease Treatment. Industry analysis & Market Report on End Stage Renal Disease Treatment is a syndicated market report, published as Global End Stage Renal Disease Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of End Stage Renal Disease Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,599.56
    		3,899.34
    		5,199.12
    		3,118.08
    		4,677.12
    		6,236.16
    		496,630.80
    		744,946.20
    		993,261.60
    		291,345.60
    		437,018.40
    		582,691.20
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo